Evidence map›Paper›PMID 27879274›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2016

Cortactin in Atherosclerosis: Just Say NO.

Patrick Belvitch, Alicia N Rizzo, Steven M Dudek

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. A New GlyT2 Variant Associated with Hyperekplexia.International journal of molecular sciences · 2025
    Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Patrick BelvitchFrom the Department of Medicine, Division of Pulmonary, Critical Care, Sleep and Allergy, University of Illinois College of Medicine, Chicago.
Alicia N RizzoFrom the Department of Medicine, Division of Pulmonary, Critical Care, Sleep and Allergy, University of Illinois College of Medicine, Chicago.
Steven M DudekFrom the Department of Medicine, Division of Pulmonary, Critical Care, Sleep and Allergy, University of Illinois College of Medicine, Chicago. sdudek@uic.edu.

Funding

Tissue Culture Biomechanical CoreP01HL058064 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAL, RATNESHWAR · 1998 to 2012
$27.8M
Structure-Function Analysis of nmMLCK in EC Barrier ResponsesP01HL126609 · NHLBI · UNIVERSITY OF FLORIDA · PI STEVEN M DUDEK · 2016 to 2026
$24.4M
Cortactin in Regulation of Pulmonary Vascular PermeabilityR56HL088144 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDEK, STEVEN M · 2015 to 2015
$422k
NHLBI NIH HHS P01 HL058064NHLBI NIH HHS P01 HL126609NHLBI NIH HHS R56 HL088144
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AtherosclerosisCortactinActinsHumansActinsCortactin

Identifiers

PMID27879274
PMCPMC5289296

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.